Intrinsiqs

Is Tenax Therapeutics, Inc. overvalued?

Tenax Therapeutics, Inc. (TENX) — key valuation metrics and fundamentals.

No verdict
Price
$14.15
Fair value
Current P/E
Normal P/E
Market cap
$237.4M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares TENX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.